DekaBank Deutsche Girozentrale’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-103,700	Closed	-$1.75M	–	1198
2014 Q4	$1.75M	Buy	103,700 +3,300	+3%	+$46.4K	0.02%	481
2014 Q3	$1.2M	Buy	100,400 +8,500	+9%	+$58K	0.02%	494
2014 Q2	$518K	Buy	91,900 +3,500	+4%	+$16.1K	0.01%	594
2014 Q1	$324K	Buy	88,400 +5,500	+7%	+$21K	0.01%	651
2013 Q4	$273K	Buy	82,900 +2,000	+2%	+$8.26K	﹤0.01%	625
2013 Q3	$343K	Buy	+80,900	New	+$383K	0.01%	590

DekaBank Deutsche Girozentrale's AVNR Position: Q1 2015 in Review

DekaBank Deutsche Girozentrale sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 103,700 shares — an estimated $1.75M sold.

DekaBank Deutsche Girozentrale first reported a position in AVNR in Q3 2013 and held it in 6 quarters. The position peaked at $1.75M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

DekaBank Deutsche Girozentrale reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 103,700 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $1.75M.
DekaBank Deutsche Girozentrale first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q3 2013 and held it in 6 quarters.
DekaBank Deutsche Girozentrale's AVANIR PHARMACEUTICALS, INC CL A position peaked at $1.75M in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2015, filed 5 May 2015.